Patient Ratings of Dialysis Care with Peritoneal Dialysis vs Hemodialysis

JAMA

Volumn 291, Issue 6, 2004, Pages 697-703

  Rubin, Haya R ^a,b,f   Fink, Nancy E ^a,b   Plantinga, Laura C ^a   Sadler, John H ^c   Kliger, Alan S ^d,e   Powe, Neil R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Independent Dialysis Foundation   (United States)

^d HOSPITAL OF SAINT RAPHAEL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; INFORMED CONSENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSING; PAIN; PATIENT SATISFACTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL WORKER; STATISTICAL ANALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PERITONEAL DIALYSIS; QUESTIONNAIRES; RENAL DIALYSIS;

EID: 1442339186     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.6.697     Document Type: Article

References (26)

1. United States Renal Data System. USRDS 2002 Annual Data Report. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2002.
2. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065-1074.
3. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17:112-117.
4. Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000;57:1720-1726.
5. King K. Patients' perspective of factors affecting modality selection: a National Kidney Foundation patient survey. Adv Ren Replace Ther. 2000;7:261-268.
6. Rubin HR, Jenckes M, Fink NE, et al, for Choices for Healthy Outcomes in Caring for ESRD. Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care: CHOICE study. Am J Kidney Dis. 1997;30:793-801.
7. Wuerth DB, Finkelstein SH, Kliger AS, Finkelstein FO. Patient assessment of quality of care in a chronic peritoneal dialysis facility. Am J Kidney Dis. 2000;35:638-643.
8. Mendelssohn DC, Mullaney SR, Jung B, Blake PG, Mehta RL. What do American nephologists think about dialysis modality selection? Am J Kidney Dis. 2001;37:22-29.
9. Powe NR, Klag MJ, Sadler JH, et al. Choices for Healthy Outcomes in Caring for End Stage Renal Disease. Semin Dial. 1996;9:9-11.
10. Wu AW, Fink NE, Cagney KA, et al. Developing a health-related quality-of-life measure for endstage renal disease: the CHOICE Health Experience Questionnaire. Am J Kidney Dis. 2001;37:11-21.
11. Athienites NV, Miskulin DC, Fernandez G, et al. Comorbidity assessment in hemodialysis and peritoneal dialysis using the Index of Coexistent Disease. Semin Dial. 2000;13:320-326.
12. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
13. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
14. Zeger SL, Liang KY, Albert PS, Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
15. Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant. 2001;16(suppl 7):20-24.
16. Valderrabano F, Golper T, Muirhead N, Ritz E, Levin A. Chronic kidney disease: why is management so uncoordinated and suboptimal? Nephrol Dial Transplant. 2001;16(suppl 7):61-64.
17. Zimmerman DL, Selick A, Singh R, Mendelssohn DC. Attitudes of Canadian nephrologists, family physicians, and patients with kidney failure toward primary care delivery for chronic dialysis patients. Nephrol Dial Transplant. 2003;18:305-309.
18. Steinman TI. Managed care, capitation, and the future of nephrology. J Am Soc Nephrol. 1997;8:1618-1623.
19. Cooper BS, Eggers PW, Edington BM. Development of an end-stage renal disease managed care demonstration. Adv Ren Replace Ther. 1997;4:332-339.
20. Eggers PW, Frankenfield DL, Greer JW, McClellan W, Owen WF Jr, Rocco MV. Comparison of mortality and intermediate outcomes between Medicare dialysis patients in HMO and fee for service. Am J Kidney Dis. 2002;39:796-804.
21. Hirth RA, Held PJ. Some of the small print on managed care proposals for end-stage renal disease. Adv Ren Replace Ther. 1997;4:314-324.
22. Nelson EC, Rubin HR, Hays RD, Meterko M. Patient judgments of hospital quality: response to questionnaire. Med Care. 1990;28:S18-S22.
23. Murray BP, Dwore RB, Gustafson G, Parsons RJ, Vorderer LH. Enrollee satisfaction with HMOs and its relationship with disenrollment. Manag Care Interface. 2000;13:55-61.
24. Rubin HR, Gandek B, Rogers WH, Kosinski M, McHorney CA, Ware JE Jr. Patients' ratings of outpatient visits in different practice settings: results from the Medical Outcomes Study. JAMA. 1993;270:835-840.
25. Medicare Payment Advisory Commission. Endstage renal disease policies in traditional Medicare. In: Report to Congress: Medicare Payment Policy. Washington, DC: Medicare Payment Advisory Commission; March 2001:128.
26. Center for Medicare and Medicaid Services Medicare Program Revisions to Payment Policies under the Physician Fee Schedule for Calendar Year 2004. Available at: http://a257.g.akamaitech.net/7/257/2422/14mar20010800/edocket.access.gpo.gov/ 2003/03-20662.htm. Accessibility verified January 7, 2004.